Mark Kruzel, MD, MBA; serves as Medical Director in Oncology at Quest Advanced Diagnostics.

Dr. Kruzel’s role bridges the gap from assay development, validation to clinical utility and he provides guidance on the appropriate utilization of testing. Recently, Dr. Kruzel has developed clinical care pathways for oncology focusing on providing access to testing in an efficacious and guideline driven manner.  In addition to his role as medical director of oncology Dr. Kruzel serves as the SW Regional Medical Director for payer access including sitting on the payer team servicing UHC, Aetna and Humana.

Dr. Kruzel has extensive research and industry experience ranging from managing an FDA trial site to commercializing a pharmaceutical compound for a start-up company.  He has published numerous peer reviewed journal articles as well as presented abstracts at both local and national conferences.  Through his role at Quest, Dr. Kruzel has developed key opinion leader strategies which help Quest advance in the field of precision medicine. 

Dr. Kruzel received his medical degree from The University of Texas at Houston – McGovern School of Medicine; he received his Master of Business Administration from Cox Business School at Southern Methodist University.  He is an active member of American Society of Clinical Oncology, Association for Molecular Pathology and American College of Healthcare Executives.